News | June 10, 2026
GSK bets big on oncology with $10.6 billion Nuvalent acquisition
Deal brings late-stage lung cancer candidates zidesamtinib and neladalkib into GSK’s portfolio
Deal brings late-stage lung cancer candidates zidesamtinib and neladalkib into GSK’s portfolio
Tomoyuki Hasegawa has been appointed CEO of FUJIFILM Biotechnologies California
Dengue, a mosquito-borne viral disease, is emerging as a growing public health threat across Africa
The graduating cohort comprised seven batches across five specialized programs
Teva said the launch strengthens its biosimilars strategy and expands access to biologic medicines across Europe
The facility integrates advanced scientific infrastructure and specialised workflows to support complex drug delivery systems, sterile injectables, and differentiated dosage forms
The industry is expected to grow significantly over the next few years as healthcare accessibility improves and insurance penetration increases
Eribulin Mesylate Injection, 1 mg/2 mL (0.5 mg/mL) single-dose vials is the bioequivalent to the reference listed drug (RLD) Halaven injection of Eisai, Inc.
The hospital successfully treats two complex high-risk cardiac patients using advanced minimally invasive heart surgeries
Fertility platform launches flagship clinic with advanced IVF tech
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
